Data on immunogenicity and reactogenicity to COVID-19 vaccination among patients receiving maintenance dialysis

Published: 4 May 2022| Version 4 | DOI: 10.17632/dv2vm47sbm.4
Faeq Husain


The data file shared in the repository contains the raw data on the humoral and cellular immunogenicity and reactogenicity of a homologous mRNA-based and vector-based SARS-CoV-2 vaccine regimen in 60 patients receiving maintenance dialysis (six with a history of COVID-19). Data include information on demographics, comorbidities, dialysis modality and vintage, baseline clinical data, and vaccine regimen. The data file also includes data on the SARS-CoV-2-specific interleukin-2 (IL-2) reactivity and interferon-γ (IFN-γ) reactivity at 4 weeks and 6 weeks following a single dose or a complete homologous dual dose SARS-CoV-2 vaccine regimen, and on the self-reported local and systemic adverse events after the first and second dose using a standardized questionnaire.